A Study of BPI-452080 in Subjects With Solid Tumors

NCT05843305 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Renal Cell Carcinoma
Von Hippel-Lindau Disease

Interventions

DRUG: BPI-452080

Sponsor

Betta Pharmaceuticals Co., Ltd.